Why the study?
Advances in acute MI treatment reduced in-hospital mortality, but post-discharge prognosis remains unacceptable. The study aimed to assess the effect of the MC-AMI comprehensive care program on all-cause mortality at 1-year follow-up.
Does the Managed Care in Acute Myocardial Infarction (MC-AMI) program reduce all-cause mortality in patients post-acute myocardial infarction?
Does the Managed Care in Acute Myocardial Infarction (MC-AMI) program reduce all-cause mortality in patients post-acute myocardial infarction?
A comprehensive post-MI managed care program significantly reduces 1-year all-cause mortality compared to standard care.
May support MC-AMI consideration post-MI; leaves open randomized confirmation before practice change.
INTRODUCTION: Advances in the acute treatment of myocardial infarction (AMI) substantially reduced in-hospital mortality, but the post-discharge prognosis is still unacceptable. The Managed Care in Acute Myocardial Infarction (MC-AMI) is a program of Poland's National Health Fund that aims at comprehensive post-AMI care to improve long-term prognosis. The aim of the study was to assess the effect of MC-AMI on all-cause mortality in one-year follow-up. METHODS: MC-AMI includes acute MI treatment, complex revascularization, cardiac rehabilitation (CR), scheduled one-year outpatient follow-up, and prevention of sudden cardiac death. In this retrospective observational study performed in a province of Silesia, Poland, we analyzed 3893 MC-AMI participants, and compared them to 6946 patients in the control group. After propensity score matching, we compared two groups of 3551 subjects each. To assess the effect of MC-AMI and other variables on mortality, we preformed a Cox regression. RESULTS: < 0.001). Besides that, older age (HR 1.47/10 y), ST-elevation AMI (HR 1.41), heart failure (HR 2.08), diabetes (HR 1.52), and dialysis (HR 2.38) were significantly associated with the primary endpoint. Among MC-AMI components, cardiac rehabilitation (HR 0.34) and strict outpatient care (HR 0.42) are the crucial factors affecting mortality reduction. CONCLUSIONS: Participation in MC-AMI reduced 1-year mortality by 38% and the effect persisted after the program had been completed.
No takes yet. Share an insight, caveat, or question.
Wita et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: